PAHO opens a new pathway to access lenacapavir for HIV prevention in Latin America and the Caribbean in Ashtip

Ashtip NewsLetter |Through an agreement with Gilead Sciences, the Organization will facilitate access to this innovation in 14 countries through its Regional Revolving Funds, complementing existing voluntary licensing arrangements and supporting a longer-term strategy for sustainable access.

PAHO Org

PAHO opens a new pathway to access lenacapavir for HIV prevention in Latin America and the Caribbean

PAHO opens a new pathway to access lenacapavir for HIV prevention in Latin America and the Caribbean

Through an agreement with Gilead Sciences, the Organization will facilitate access to this innovation in 14 countries through its Regional Revolving Funds, complementing existing voluntary licensing arrangements and supporting a longer-term strategy for sustainable access.Washington, D.C., September 15, 2026 (PAHO) – The Pan American Health…